High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$389K
$389,614
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
NMRA
S
Neumora Therapeutics, Inc.
Aurora Daljit Singh
• Officer • See Remarks
Sell to Cover
2026-02-17
$21,917
|
||||||
| NMRA |
Neumora Therapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-02-17 | $21,917 | S | Form 4 |
|
NMRA
S
Neumora Therapeutics, Inc.
BERNS PAUL L
• Officer • See Remarks
Sell to Cover
2026-02-17
$34,459
|
||||||
| NMRA |
Neumora Therapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-02-17 | $34,459 | S | Form 4 |
|
NMRA
S
Neumora Therapeutics, Inc.
Milligan Michael Lee
• Officer • See Remarks
Sell to Cover
2026-02-17
$5,119
|
||||||
| NMRA |
Neumora Therapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-02-17 | $5,119 | S | Form 4 |
| NMRA |
Neumora Therapeutics, Inc.
|
President
Sell to Cover
|
2026-02-17 | $21,093 | S | Form 4 |
|
NMRA
S
Neumora Therapeutics, Inc.
Aurora Daljit Singh
• Officer • See Remarks
10b5-1 Sell
2025-11-11
$307,026
|
||||||
| NMRA |
Neumora Therapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-11-11 | $307,026 | S | Form 4 |